( Northwestern University ) A new study underscores the importance for women with a family history of breast or ovarian cancer to get genetic testing for the BRCA1 and BRCA2 genes that make them more likely to develop lethal breast or ovarian cancer, says a Northwestern Medicine oncologist. In a JAMA editorial, she tells what the findings mean to women with the gene mutations and how preventive ...